Jazz Pharmaceuticals plc (JAZZ)
NASDAQ: JAZZ · Real-Time Price · USD
186.95
-1.32 (-0.70%)
At close: Apr 2, 2026, 4:00 PM EDT
187.25
+0.30 (0.16%)
After-hours: Apr 2, 2026, 4:53 PM EDT

Jazz Pharmaceuticals Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023
Period Ending
Dec '25 Dec '24 Dec '23
Net Income
-356.15560.12414.83
Depreciation & Amortization
696.3660.07638.7
Stock-Based Compensation
291.13248.05226.84
Other Adjustments
705.594.416.08
Change in Receivables
-106.28-21.12-51.88
Changes in Inventories
-86.04-45.54-13.42
Changes in Accounts Payable
39.85-20.079.6
Changes in Accrued Expenses
77.186.16-23.25
Changes in Income Taxes Payable
37.22-14.7425.22
Changes in Other Operating Activities
57.05-61.41-150.71
Operating Cash Flow
1,3561,3961,092
Operating Cash Flow Growth
-2.88%27.83%-
Capital Expenditures
-58.75-38.07-23.96
Purchases of Intangible Assets
-151-10-19
Purchases of Investments
-1,830-1,305-390.1
Proceeds from Sale of Investments
1,360845270
Payments for Business Acquisitions
-858.05--
Other Investing Activities
28.17--
Investing Cash Flow
-1,510-508.2-163.06
Long-Term Debt Issued
-980.77-
Long-Term Debt Repaid
-781-606-31
Net Long-Term Debt Issued (Repaid)
-781374.77-31
Issuance of Common Stock
107.8620.6546.46
Repurchase of Common Stock
-125.02-311.43-269.76
Net Common Stock Issued (Repurchased)
-17.16-290.78-223.3
Other Financing Activities
-75.22-63.47-50.95
Financing Cash Flow
-873.3820.52-305.25
Effect of Exchange Rate Changes on Cash and Cash Equivalents
6.56-1.681.14
Net Cash Flow
-1,021906.55624.83
Free Cash Flow
1,2971,3581,068
Free Cash Flow Growth
-4.48%27.13%-
FCF Margin
30.39%33.37%27.86%
Free Cash Flow Per Share
21.2720.5714.82
Levered Free Cash Flow
-374.431,501846.01
Unlevered Free Cash Flow
519.171,4221,274
Updated Feb 24, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q